Melisa Tuncer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Melisa Tuncer has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Cakir
Department of Genetics and Bioengineering, Istanbul Bilgi University, Istanbul, Turkey
1 shared publication - Ceyda Oksel Karakus
Department of Bioengineering, Izmir Institute of Technology, Izmir, Turkey
1 shared publication - Deniz T. Yucesoy
Department of Bioengineering, Izmir Institute of Technology, Gülbahçe, Urla/Izmir, Turkey
1 shared publication - Hilal Taymaz-Nikerel
Department of Genetics and Bioengineering, Istanbul Bilgi University, Istanbul, Turkey
1 shared publication - Ozlem Ulucan
Department of Genetics and Bioengineering, Istanbul Bilgi University, Eyupsultan, Turkey
1 shared publication
Latest Publications
- Open Access
- 13 February 2025
- Published by Springer Nature in JOM
- Vol. 77 (7) , 5064-5075
Investigating Early-Stage Mineralization Behavior and Bioactivity of Acid-Free Bioactive Glass 45S5 with Enhanced Dissolution Kinetics
Nanostructured bioactive glass (BG) was synthesized through an acid-free sol–gel route (bioglass-AF) and the conventional acid-catalyst sol–gel process (bioglass-AC). The aim here is to eliminate the risk of residual acidic components in the BG while enhancing its functionality through nano-scale propduction. Scanning electron microscopy revealed the presence of highly porous structures and dense agglomerates composed of particles with a mean diameter of 45 nm in both samples. Bioglass-AC and bioglass-AF had specific surface areas of 1.48 m2/g and 2.73 m2/g, respectively, with an average pore size of ~ 5 nm. Faster mineralization kinetics were evident in bioglass-AF, compared to bioglass-AC, in Hepes-buffered salt solution. Following 14 days of immersion in artificial saliva, bioglass-AC and bioglass-AF lost 16% and 20% of their initial weight, respectively, confirming their bioactivity. None of the synthesized BGs stimulated cell growth up to 24 h but longer exposure to moderate concentrations (1.25 and 2.5 mg/mL) of bioglass-AF significantly enhanced cell viability, reaching 170% at 48 h. Overall, the comparative in vitro investigations proved that nano-structured 45S5 bioglass powders with improved mineralization and dissolution kinetics can be produced with an acid-free route, eliminating the risk of residual acidic components in the final product.
- 13 February 2025
- Published by Springer Nature in JOM
- Vol. 77 (7) , 5064-5075
Open AccessInvestigating Early-Stage Mineralization Behavior and Bioactivity of Acid-Free Bioactive Glass 45S5 with Enhanced Dissolution Kinetics
Nanostructured bioactive glass (BG) was synthesized through an acid-free sol–gel route (bioglass-AF) and the conventional acid-catalyst sol–gel process (bioglass-AC). The aim here is to eliminate the risk of residual acidic components in the BG while enhancing its functionality through nano-scale propduction. Scanning electron microscopy revealed the presence of highly porous structures and dense agglomerates composed of particles with a mean diameter of 45 nm in both samples. Bioglass-AC and bioglass-AF had specific surface areas of 1.48 m2/g and 2.73 m2/g, respectively, with an average pore size of ~ 5 nm. Faster mineralization kinetics were evident in bioglass-AF, compared to bioglass-AC, in Hepes-buffered salt solution. Following 14 days of immersion in artificial saliva, bioglass-AC and bioglass-AF lost 16% and 20% of their initial weight, respectively, confirming their bioactivity. None of the synthesized BGs stimulated cell growth up to 24 h but longer exposure to moderate concentrations (1.25 and 2.5 mg/mL) of bioglass-AF significantly enhanced cell viability, reaching 170% at 48 h. Overall, the comparative in vitro investigations proved that nano-structured 45S5 bioglass powders with improved mineralization and dissolution kinetics can be produced with an acid-free route, eliminating the risk of residual acidic components in the final product.
- 21 June 2021
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 21 (6) , 673-681
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection
One in every ten drug candidates fail in clinical trials mainly due to efficacy and safety related issues, despite in-depth preclinical testing. Even some of the approved drugs such as chemotherapeutics are notorious for their side effects that are burdensome on patients. In order to pave the way for new therapeutics with more tolerable side effects, the mechanisms underlying side effects need to be fully elucidated. In this work, we addressed the common side effects of chemotherapeutics, namely alopecia, diarrhea and edema. A strategy based on Random Forest algorithm unveiled an expression signature involving 40 genes that predicted these side effects with an accuracy of 89%. We further characterized the resulting signature and its association with the side effects using functional enrichment analysis and protein-protein interaction networks. This work contributes to the ongoing efforts in drug development for early identification of side effects to use the resources more effectively.
- 21 June 2021
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 21 (6) , 673-681
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selection
One in every ten drug candidates fail in clinical trials mainly due to efficacy and safety related issues, despite in-depth preclinical testing. Even some of the approved drugs such as chemotherapeutics are notorious for their side effects that are burdensome on patients. In order to pave the way for new therapeutics with more tolerable side effects, the mechanisms underlying side effects need to be fully elucidated. In this work, we addressed the common side effects of chemotherapeutics, namely alopecia, diarrhea and edema. A strategy based on Random Forest algorithm unveiled an expression signature involving 40 genes that predicted these side effects with an accuracy of 89%. We further characterized the resulting signature and its association with the side effects using functional enrichment analysis and protein-protein interaction networks. This work contributes to the ongoing efforts in drug development for early identification of side effects to use the resources more effectively.